Stay updated on Entrectinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.

Latest updates to the Entrectinib in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.6.3 has been added, replacing the previous Revision: v3.6.0. This update reflects a newer underlying software version powering the page.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now indicates the study is no longer recruiting and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study); it also updates the header formatting from 'Intervention / Treatment' to 'Intervention/Treatment' and includes a site revision tag (Revision: v3.6.0).SummaryDifference0.2%

- Check29 days agoChange DetectedThe page now displays the latest Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor build update.SummaryDifference0.0%

- Check36 days agoChange DetectedNew date values were added (e.g., 2026-05-27 and 2027-06-30) and old dates (e.g., 2026-03-06, 2026-05-14, 2026-03-05, 2026-03) were removed, reflecting updates to the study timeline and last-updated timestamps on the record.SummaryDifference0.1%

- Check51 days agoChange DetectedPublications section gained a new citation for a comparative effectiveness analysis of entrectinib and crizotinib in ROS1+ NSCLC. The Erratum reference for that publication was removed and the page revision tag updated to v3.5.4.SummaryDifference0.0%

- Check58 days agoChange DetectedA new bibliographic reference was added to the Publications section. It cites the 2025 NCCN Gastric Cancer guidelines (Ajani et al.).SummaryDifference0.0%

Stay in the know with updates to Entrectinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.